SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-18-038083
Filing Date
2018-02-09
Accepted
2018-02-09 16:35:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d533497dsc13ga.htm SC 13G/A 54723
  Complete submission text file 0001193125-18-038083.txt   56364
Mailing Address 19 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 19 FIRSTFIELD ROAD GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Subject) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-80900 | Film No.: 18592286
SIC: 2834 Pharmaceutical Preparations

Mailing Address 19 FIRSTFIELD ROAD SUITE 200 GAITHERSBURG MD 20878
Business Address 5 RUE DE LA BAUME PARIS I0 75008 (240) 654-1450
Truffle Capital S.A.S. (Filed by) CIK: 0001706034 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC 13G/A